OTC denture cushion downclassifications sought by Mentholatum and Brimms.
This article was originally published in The Gray Sheet
Executive SummarySOFT PLASTIC DENTURE CUSHION DOWNCLASSIFICATION: FDA SAFETY CONCERNS "are not applicable if cushions are only used temporarily until a dentist can be seen," Mentholatum argues in a July 26 petition requesting that FDA reclassify the over-the-counter devices from Class III to Class I. The petition was submitted in response to FDA's July 11 proposed call for premarket approval applications for OTC denture cushions or pads and repair kits ("The Gray Sheet" July 17, p. 15). The proposed rule covers all denture cushions/pads except those made of wax-impregnated cotton cloth and intended for one-day use, which are in Class I.
You may also be interested in...
Novartis’s first digital innovation hub in Asia is launched in India, where the Swiss company hopes to ally with partners to deliver digital solutions for patients at scale.
Senate Finance Committee’s approach to penalize companies for raising WAC list prices is not a ‘price control,’ but a reasonable approach to change the incentives that distort pricing in the supply chain, US HHS Secretary Alex Azar says.
With the pre-GDUFA backlog largely acted upon, the FDA expects ANDA approvals to decrease, but supplement actions to increase in FY 2020 and FY 2021.